You're using a browser that isn't supported by Facebook, so we've redirected you to a simpler version to give you the best experience.
Enter your email address below to receive the latest news and earnings results for NVCR and its competitors with MarketBeat's FREE daily newsletter.
TTFields is an innovative treatment modality approved for both newly diagnosed and recurrent GBM in US, Europe and Japan. The mechanism of action has relevance in other cancers. Novocure continues to explore the use of TTFields in a number of cancers of the central nervous system including brain metastases from non-small cell lung cancer (NSCLC) in the ongoing phase III METIS trial.
Agentes imunossupressores saiba como as ciclofosfamidas também podem ser indicados no procedimento da neuropatia do Género crônico que têm a oportunidade de ser resistente a outros tratamentos.
Novocure’s performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, environmental, regulatory and political conditions as well as issues arising from the COVID-19 pandemic and other more specific risks and uncertainties facing Novocure such as those set forth in its Annual Report on Form 10-K filed on February 23, 2023, and subsequent filings with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Novocure does not intend to update publicly any forward-looking statement, except as required by law. Any forward-looking statements herein speak only as of the date hereof. The Private Securities Litigation Reform Act of 1995 permits this discussion.
Download PDF The three most common types of brain tumour are intracranial metastases, which spread from other primary sites of disease; meningiomas, which are mostly benign; and glioblastoma multiforme (GBM), which is the most common and lethal primary malignant brain tumour in adults. Median survival in GBM following standard of care treatment is approximately 15 months nervocure from the time of diagnosis. There are currently no curative therapeutic options for GBM and treatment includes maximal surgical resection, radiation therapy (RT) and chemotherapy.
Aproveite Presentemente e Garanta seu Desconto Especial: Nãeste deixe de modo a depois! Clique aqui para ativar o cupom de Abatimento exclusivo do site oficial e comece tua jornada rumo ao alívio DE dores nos nervos.
investor relations home stock information corporate presentation SEC filings press releases corporate governance
Continuar comprando Finalizar compra Ir para este carrinho Não foi possível adicionar o Resultado ao carrinho
Figure 2: Effects of TTFields on replicating cells. TTFields exert directional forces on polar microtubules and interfere with the assembly of the normal mitotic spindle and subsequently trigger mitotic cell death.
We join together with patients, caregivers and advocacy partners in their dedication to redefine living with cancer.
The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Os sintomas da neuropatia facial hereditária podem vir a variar em gravidade e idade de início. Geralmente, a fraqueza facial ocorre de forma repentina e É possibilitado a afetar qualquer lado do rosto.
Ongoing research suggests that TTFields may also inhibit DNA damage repair, impair cellular migration and invasion4 and upregulate autophagy5. The resulting daughter cells exhibit various forms of cell death including immunogenic cell death, suggesting that combining TTFields with immunotherapies may enhance the body’s own antitumour immunity6.